NYSE$SES
Ses Ai Corp · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
SES AI reported Q3 2025, revenue of $7.1M, net loss of $45M.
For Q3 2025, SES AI reported revenue of $7.1M, a net loss of $45M. Management discusses segment performance, capital allocation, and sector risks in the quarterly filing.
- Revenue $7.1M.
- Net loss $45M.
- SES AI MD&A covers liquidity, credit, and operating priorities.
Headline financials
Revenue & EPS history
Ses Ai · Revenue · Quarterly
$7.12M
Forward guidance
Clinical or pre-revenue biotech outlook centers on trial milestones, partnerships, and cash runway.
Tailwinds
- Pipeline milestones and collaboration optionality.
- Cash and marketable securities fund operations.
Headwinds
- Trial failure or delay risk.
- Dilution from future financings.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
+1.5%
Avg return
Earnings day
-0.7%
Avg return
5 days after
-7.7%
Avg return
30 days after
57%
12 / 21 earnings
Positive
+28.4%
Q1 2022
Best reaction
-36.3%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2024 | — | — | — | |
| Q1 2026 | -4.9% | -16.4% | -0.8% | |
| Q4 2025 | -36.3% | -25.7% | -41.8% | |
| Q3 2025 | -1.8% | +4.0% | -2.7% | |
| Q2 2025 | -23.7% | -17.5% | -23.4% | |
| Q1 2025 | +18.5% | +3.5% | +9.6% | |
| Q4 2024 | -5.1% | -31.6% | -35.2% | |
| Q3 2024 | -12.7% | -15.7% | -32.3% | |
| Q1 2024 | -5.4% | -6.1% | -15.5% | |
| Q4 2023 | +23.2% | +21.7% | +20.3% | |
| Q3 2023 | +5.3% | +2.6% | +12.2% | |
| Q2 2023 | +2.7% | -4.3% | -22.4% | |
| Q1 2023 | +10.7% | +2.7% | +42.3% | |
| Q4 2022 | +1.5% | +0.4% | -11.2% | |
| Q3 2022 | +7.4% | +5.0% | -24.5% | |
| Q2 2022 | +11.6% | +11.2% | +3.4% | |
| Q1 2022 | +28.4% | +50.0% | -7.1% | |
| Q4 2021 | +6.6% | +1.9% | -26.5% | |
| Q3 2021 | +5.7% | +0.4% | -5.4% | |
| Q2 2021 | +0.2% | +0.4% | +1.1% | |
| Q1 2021 | -0.7% | -0.3% | -1.2% | |
| Q4 2020 | -0.7% | -0.3% | -1.2% | |
| Q3 2019 | — | — | — | |
| Q2 2019 | — | — | — | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — | |
| Q4 2017 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro